Postinjury scopolamine administration in experimental traumatic brain injury

Bruce G Lyeth, Mikelene Ray, Robert J. Hamm, James Schnabel, Joseph J. Saady, Alphonse Poklis, Larry W. Jenkins, Steven K. Gudeman, Ronald L. Hayes

Research output: Contribution to journalArticle

61 Citations (Scopus)

Abstract

A single bolus dose of scopolamine (1.0 mg/kg) or saline (equal volume) was injected (i.p.) at 15, 30 or 60 min after fluid percussion traumatic brain injury in the rat. Scopolamine administered at 15 min postinjury significantly reduced beam walking deficits and body weight loss assessed for 5 days after injury. Scopolamine treatment at 30 or 60 min postinjury had no effect on behavioral outcome assessed for 5 days after injury. Plasma concentrations of scopolamine were measured with a radioreceptor assay. The plasma half-life for scopolamine was 21.6 min in injured rats and 17.3 min in normal rats (P < 0.05). These results, along with evidence from previous studies, suggest that a brief period of excessive neuronal excitation can produce relatively long-lasting behavioral deficits. The temporal effectiveness of receptor antagonist intervention in this process appears to be brief.

Original languageEnglish (US)
Pages (from-to)281-286
Number of pages6
JournalBrain Research
Volume569
Issue number2
DOIs
StatePublished - Jan 13 1992
Externally publishedYes

Fingerprint

Scopolamine Hydrobromide
Percussion
Radioligand Assay
Wounds and Injuries
Walking
Half-Life
Weight Loss
Body Weight
Traumatic Brain Injury

Keywords

  • Acetylcholine
  • Behavior
  • Muscarine
  • Radioreceptor assay
  • Rat
  • Scopolamine
  • Traumatic brain injury

ASJC Scopus subject areas

  • Developmental Biology
  • Molecular Biology
  • Clinical Neurology
  • Neuroscience(all)

Cite this

Lyeth, B. G., Ray, M., Hamm, R. J., Schnabel, J., Saady, J. J., Poklis, A., ... Hayes, R. L. (1992). Postinjury scopolamine administration in experimental traumatic brain injury. Brain Research, 569(2), 281-286. https://doi.org/10.1016/0006-8993(92)90640-U

Postinjury scopolamine administration in experimental traumatic brain injury. / Lyeth, Bruce G; Ray, Mikelene; Hamm, Robert J.; Schnabel, James; Saady, Joseph J.; Poklis, Alphonse; Jenkins, Larry W.; Gudeman, Steven K.; Hayes, Ronald L.

In: Brain Research, Vol. 569, No. 2, 13.01.1992, p. 281-286.

Research output: Contribution to journalArticle

Lyeth, BG, Ray, M, Hamm, RJ, Schnabel, J, Saady, JJ, Poklis, A, Jenkins, LW, Gudeman, SK & Hayes, RL 1992, 'Postinjury scopolamine administration in experimental traumatic brain injury', Brain Research, vol. 569, no. 2, pp. 281-286. https://doi.org/10.1016/0006-8993(92)90640-U
Lyeth, Bruce G ; Ray, Mikelene ; Hamm, Robert J. ; Schnabel, James ; Saady, Joseph J. ; Poklis, Alphonse ; Jenkins, Larry W. ; Gudeman, Steven K. ; Hayes, Ronald L. / Postinjury scopolamine administration in experimental traumatic brain injury. In: Brain Research. 1992 ; Vol. 569, No. 2. pp. 281-286.
@article{851b57db1d5a4864a3ed94149fd0a5cb,
title = "Postinjury scopolamine administration in experimental traumatic brain injury",
abstract = "A single bolus dose of scopolamine (1.0 mg/kg) or saline (equal volume) was injected (i.p.) at 15, 30 or 60 min after fluid percussion traumatic brain injury in the rat. Scopolamine administered at 15 min postinjury significantly reduced beam walking deficits and body weight loss assessed for 5 days after injury. Scopolamine treatment at 30 or 60 min postinjury had no effect on behavioral outcome assessed for 5 days after injury. Plasma concentrations of scopolamine were measured with a radioreceptor assay. The plasma half-life for scopolamine was 21.6 min in injured rats and 17.3 min in normal rats (P < 0.05). These results, along with evidence from previous studies, suggest that a brief period of excessive neuronal excitation can produce relatively long-lasting behavioral deficits. The temporal effectiveness of receptor antagonist intervention in this process appears to be brief.",
keywords = "Acetylcholine, Behavior, Muscarine, Radioreceptor assay, Rat, Scopolamine, Traumatic brain injury",
author = "Lyeth, {Bruce G} and Mikelene Ray and Hamm, {Robert J.} and James Schnabel and Saady, {Joseph J.} and Alphonse Poklis and Jenkins, {Larry W.} and Gudeman, {Steven K.} and Hayes, {Ronald L.}",
year = "1992",
month = "1",
day = "13",
doi = "10.1016/0006-8993(92)90640-U",
language = "English (US)",
volume = "569",
pages = "281--286",
journal = "Brain Research",
issn = "0006-8993",
publisher = "Elsevier",
number = "2",

}

TY - JOUR

T1 - Postinjury scopolamine administration in experimental traumatic brain injury

AU - Lyeth, Bruce G

AU - Ray, Mikelene

AU - Hamm, Robert J.

AU - Schnabel, James

AU - Saady, Joseph J.

AU - Poklis, Alphonse

AU - Jenkins, Larry W.

AU - Gudeman, Steven K.

AU - Hayes, Ronald L.

PY - 1992/1/13

Y1 - 1992/1/13

N2 - A single bolus dose of scopolamine (1.0 mg/kg) or saline (equal volume) was injected (i.p.) at 15, 30 or 60 min after fluid percussion traumatic brain injury in the rat. Scopolamine administered at 15 min postinjury significantly reduced beam walking deficits and body weight loss assessed for 5 days after injury. Scopolamine treatment at 30 or 60 min postinjury had no effect on behavioral outcome assessed for 5 days after injury. Plasma concentrations of scopolamine were measured with a radioreceptor assay. The plasma half-life for scopolamine was 21.6 min in injured rats and 17.3 min in normal rats (P < 0.05). These results, along with evidence from previous studies, suggest that a brief period of excessive neuronal excitation can produce relatively long-lasting behavioral deficits. The temporal effectiveness of receptor antagonist intervention in this process appears to be brief.

AB - A single bolus dose of scopolamine (1.0 mg/kg) or saline (equal volume) was injected (i.p.) at 15, 30 or 60 min after fluid percussion traumatic brain injury in the rat. Scopolamine administered at 15 min postinjury significantly reduced beam walking deficits and body weight loss assessed for 5 days after injury. Scopolamine treatment at 30 or 60 min postinjury had no effect on behavioral outcome assessed for 5 days after injury. Plasma concentrations of scopolamine were measured with a radioreceptor assay. The plasma half-life for scopolamine was 21.6 min in injured rats and 17.3 min in normal rats (P < 0.05). These results, along with evidence from previous studies, suggest that a brief period of excessive neuronal excitation can produce relatively long-lasting behavioral deficits. The temporal effectiveness of receptor antagonist intervention in this process appears to be brief.

KW - Acetylcholine

KW - Behavior

KW - Muscarine

KW - Radioreceptor assay

KW - Rat

KW - Scopolamine

KW - Traumatic brain injury

UR - http://www.scopus.com/inward/record.url?scp=0026526801&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0026526801&partnerID=8YFLogxK

U2 - 10.1016/0006-8993(92)90640-U

DO - 10.1016/0006-8993(92)90640-U

M3 - Article

C2 - 1540831

AN - SCOPUS:0026526801

VL - 569

SP - 281

EP - 286

JO - Brain Research

JF - Brain Research

SN - 0006-8993

IS - 2

ER -